Access to affordable drugs hinges on competition. Study notes lowest prices in India, South Africa.
A new study finds that developing nations with greater market competition for antiretrovirals and more generic producers tend to have cheaper antiretroviral drugs available through the private sector.
D019380:Anti-HIV Agents / Q000191:economics / Q000600:supply & distribution*; D016527:Drug Costs / Q000706:statistics & numerical data*; D004465:Economic Competition; D006297:Health Services Accessibility; D006801:Humans; D007194:India; D013019:South Africa
D019380:Anti-HIV Agents